Minaam Abbas, who got a place at the University of Cambridge after a Skype interview, has graduated with first class honours. Minaam is a co-founder of biotech start-up company AngioClast, which is trying to develop a revolutionary treatment for brain tumours. AngioClast is supported by the Accelerate Cambridge programme at Cambridge Judge Business School.
Read the full article [cambridge-news.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments